Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 25

Results: 10

Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3039, doi. 10.1038/onc.2012.321
By:
- Chen, D W-C;
- Saha, V;
- Liu, J-Z;
- Schwartz, J-M;
- Krstic-Demonacos, M
Publication type:
Article
MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3019, doi. 10.1038/onc.2012.323
By:
- Ke, G;
- Liang, L;
- Yang, J M;
- Huang, X;
- Han, D;
- Huang, S;
- Zhao, Y;
- Zha, R;
- He, X;
- Wu, X
Publication type:
Article
C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3101, doi. 10.1038/onc.2012.314
By:
- Muller, P;
- Ruckova, E;
- Halada, P;
- Coates, P J;
- Hrstka, R;
- Lane, D P;
- Vojtesek, B
Publication type:
Article
Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3049, doi. 10.1038/onc.2012.320
By:
- Bianchi-Smiraglia, A;
- Paesante, S;
- Bakin, A V
Publication type:
Article
MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3071, doi. 10.1038/onc.2012.318
By:
- Gong, J;
- Zhang, J-P;
- Li, B;
- Zeng, C;
- You, K;
- Chen, M-X;
- Yuan, Y;
- Zhuang, S-M
Publication type:
Article
Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3080, doi. 10.1038/onc.2012.317
By:
- Chander, H;
- Truesdell, P;
- Meens, J;
- Craig, A W B
Publication type:
Article
NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3009, doi. 10.1038/onc.2012.453
By:
- Fedorenko, I V;
- Gibney, G T;
- Smalley, K S M
Publication type:
Article
Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3059, doi. 10.1038/onc.2012.319
By:
- Chell, V;
- Balmanno, K;
- Little, A S;
- Wilson, M;
- Andrews, S;
- Blockley, L;
- Hampson, M;
- Gavine, P R;
- Cook, S J
Publication type:
Article
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3091, doi. 10.1038/onc.2012.315
By:
- Wang, P;
- Dong, Q;
- Zhang, C;
- Kuan, P-F;
- Liu, Y;
- Jeck, W R;
- Andersen, J B;
- Jiang, W;
- Savich, G L;
- Tan, T-X;
- Auman, J T;
- Hoskins, J M;
- Misher, A D;
- Moser, C D;
- Yourstone, S M;
- Kim, J W;
- Cibulskis, K;
- Getz, G;
- Hunt, H V;
- Thorgeirsson, S S
Publication type:
Article
Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas.
Published in:
Oncogene, 2013, v. 32, n. 25, p. 3028, doi. 10.1038/onc.2012.329
By:
- Wolf, S;
- Rudolph, C;
- Morgan, M;
- Büsche, G;
- Salguero, G;
- Stripecke, R;
- Schlegelberger, B;
- Baum, C;
- Modlich, U
Publication type:
Article